Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Lexicon Pharmaceuticals Inc.
DescriptionSmall molecule inhibitor of LIM domain kinase 2 (LIMK2)
Molecular Target LIM domain kinase 2 (LIMK2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationGlaucoma
Indication DetailsTreat primary open-angle glaucoma or ocular hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today